MedPath

SEMGLEE

SEMGLEE

Approved
DIN Number

02526441

Drug Class

Human

Market Date

Oct 14, 2022

Company
HC

biocon sdn.bhd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02526441
AIG Number0147062001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AE04 INSULIN GLARGINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

INSULIN GLARGINEActive
Strength: 100 UNIT / ML
Monograph: INSULIN GLARGINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.